Yushma Bhurruth-Alcor
Executive Director, Chemistry | Drug Discovery and Development | Consulting
- Role
- Director, Medicinal Chemistry at Exelixis
- Location
- San Francisco, CA, US
- LinkedIn followers
- 500 followers
About Yushma Bhurruth-Alcor
Drug Discovery Executive with 17+ years of global pharma and biotech experience, PMP and RAPS certified• Founder & CEO of YBA Consulting LLC• Inventor of RPT1G, a first-in-class NAMPT inhibitor, granted orphan drug designation in AML• End-to-end small molecule discovery (Target ID to IND), experience with degraders and molecular glues• Integrates Medicinal Chemistry, ADME/DMPK, CMC, regulatory, and IP to deliver high-quality clinical candidates with speed and rigor• Known for rigorous data-driven decision making, portfolio prioritization, and building teams that translate science into value with the highest levels of excellence• Therapeutic areas: dermatology, oncology, metabolic and rare diseases• Biological targets: enzymes, epigenetics, GPCRs, ion channels, nuclear receptors, protein-protein interactions • Target-based and phenotypic screening
Experience
Director, Medicinal Chemistry
Jan 2025 — Present · Alameda, CA, US
Education
Queen Elizabeth College, Mauritius
A levels, Science
1991 — 1998
ESPCI Paris - PSL
Diplôme d'Ingénieur de l'ESPCI
2000 — 2004
Université de Bordeaux
DEUG Sciences de la Matière, Physical Sciences
1998 — 2000
Imperial College London
PhD, Chemistry
2004 — 2007
Ecole normale supérieure
DEA Research Project, Carbohydrate Chemistry
2003 — 2004
École Polytechnique
DEA, Chemistry
2003 — 2004
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.